Pharmaceuticals, devices and care — 71 companies from 18 indices, 24 of them large drug manufacturers. The median gross margin is 64.5% (30 August 2026), the highest of any sector except real estate, where the number is an accounting artefact rather than an advantage. Here it is the durable-advantage signal that Buffett's lens weighs second heaviest.